Public health authorities in the United States are investigating what appears to be a second outbreak of fungal infections associated with compounded steroid injections. The compounding pharmacy being investigated has recalled all lots of products that are intended to be sterile.
The suspected outbreak has spurred a multistate investigation by authorities from the US Food and Drug Administration (FDA), the US Centers for Disease Control and Prevention (CDC), and local public health authorities from Illinois, North Carolina, Florida, and Tennessee. The investigation comes on the heels of an ongoing outbreak of fungal meningitis cases caused by contaminated steroid injections produced by a Massachusetts-based compounding pharmacy that began last fall and that caused illness in more than 740 patients, killing 55 of them.
Kuehn BM. CDC Probes New Outbreak Associated With Compounded Steroids. JAMA. 2013;309(24):2541. doi:10.1001/jama.2013.7701
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: